Change - Announcement of Cessation::Cessation of Ng Boon Eng as Independent Director

Issuer & Securities

Issuer/ Manager
QUANTUM HEALTHCARE LIMITED
Securities
QUANTUM HEALTHCARE LIMITED - SGXE57350022 - V8Y
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
14-Apr-2025 21:35:05
Status
New
Announcement Sub Title
Cessation of Ng Boon Eng as Independent Director
Announcement Reference
SG250414OTHRZS9D
Submitted By (Co./ Ind. Name)
Thomas Tan Gim Chua
Designation
Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. ("Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Lim Hui Ling, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, sponsorship@ppcf.com.sg.

Additional Details

Name Of Person
Ng Boon Eng
Age
54
Is effective date of cessation known?
Yes
If yes, please provide the date
30/04/2025
Detailed Reason (s) for cessation
Due to his own professional and personal commitments, Mr Ng will be retiring from office upon the conclusion of the forthcoming Annual General Meeting to be held on 30 April 2025. He will concurrently relinquish his position as Chairman of the Audit Committee and member of the Remuneration Committee. There is no notice period for Mr Ng's retirement. The Board would like to express its heartfelt gratitude towards Mr Ng for his invaluable and significant contributions to the Company during his tenure of service.

After having interviewed Mr Ng and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that save as disclosed in this announcement, there are no other material reasons for the retirement of Mr Ng as an Independent Director of the Company.

Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Yes
If Yes, Please provide full details
Mg Ng's retirement will result in the Audit Committee having lesser than the minimum requirement of three members pursuant to Rule 704(7) of the Catalist Rules.

The Company has commenced looking for a suitable candidate to be appointed as an Independent Director in place of Mr Ng and to reconstitute the Board within two months, but in any case, no later than three months and will make the appropriate announcement(s) in due course.
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
30/07/2021
Does the AC have a minimum of 3 members (taking into account this cessation)?
No
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
2
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Audit Committee Chairman and Member of the Remuneration Committee
Role and responsibilities
Independent Director, Audit Committee Chairman and Member of the Remuneration Committee
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Nil
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
QT Vascular Limited
Present
Capstone Investment Corporate Finance Pte. Ltd. (previously known as CEL Impetus Corporate Finance Pte.Ltd.)